Find a Center Glossary
Momentum Clinical Trial
HomeAboutRequest InformationFAQContact Us

What is the Momentum Clinical Trial
A clinical trial conducted to see if patients hospitalized with decompensated heart failure and are inadequately responding to medication will...

Congestive Heart Failure
CHF is the acronym for congestive heart failure, an often misunderstood disorder in which the heart is...

Cancion® System
A medical device that was evaluated for its risks and benefits in patients hospitalized with decompensated heart failure...

New Press Release
Orqis Medical's Cancion System Significantly Increases Cardiac Performance: MOMENTUM Trial Results Presented at ACC 2008

Welcome

Latest MOMENTUM Trial News

Orqis® Medical Corporation announced that the company’s MOMENTUM Trial results were presented during the Late Breaking Clinical Trials session at the annual American College of Cardiology (ACC) meeting in Chicago. The MOMENTUM Trial evaluated the percutaneous Cancion System in patients hospitalized with heart failure.

 

Barry Greenberg, M.D., Director, Advanced Heart Failure Treatment Program, University of California San Diego Medical Center, and National Principal Investigator for the MOMENTUM Trial, presented, “Efficacy and Safety of Continuous Aortic Flow Augmentation in Patients Hospitalized with Acute Decompensated Heart Failure: Results of the MOMENTUM Trial."

 

“MOMENTUM is a landmark study examining the hemodynamic and clinical effects of the Cancion System in managing patients hospitalized with heart failure inadequately responsive to medical therapy,” stated Dr. Barry Greenberg. 

 

Mr. Ken Charhut, President and CEO, Orqis Medical, stated, "MOMENTUM proved that the Cancion System significantly improves cardiac performance." He continued, "Orqis’ unique aortic flow therapy bridges the gap between medical management and more invasive procedures without ever touching the heart."

Clinical TrialsTerms of UsePrivacy Statement
 

Copyright 2007 Orqis Medical Corporation and Orqis International GmbH. Orqis, Cancion, Exeleras, CRS and the heart halo are trademarks of Orqis Medical Corporation in the United States and other countries worldwide. Protected by US and International patents. All rights reserved. CAUTION: Cancion System is Investigational Device. Limited by Federal (United States) Law to Investigational Use. Not Available for Sale in the United States.